SKIP TO MAIN CONTENT

Sirtex shares up and down after CEO axed

Shares in liver cancer biotech Sirtex leaped 1.52 per cent and then slipped 0.57 per cent into the red before closing lower at $15.82.

Gilman Wong
Sirtex shares have bounced around following the company's firing of chief executive Gilman Wong. (AAP)

1 min read

Published

Source: AAP


Skip to article content

Sirtex Medical shares have been subject to a yo-yo trading session following the medical device company's decision to fire chief executive Gilman Wong at the end of last week.

Shares in the liver cancer biotech firm leaped 1.52 per cent in the first few minutes of trade on Monday and then slipped 0.57 per cent into the red before sitting flat after an hour.

The stock continued to move up and down throughout the day, eventually closing at $15.82 - down two cents, or 0.13 per cent.

Sirtex axed Mr Wong after the market closed on Friday over his trading in the company's shares.


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world